Home » Newsletters » BioWorld Science

BioWorld Science

July 29, 2013

View Archived Issues

Identification and suppression of the neuronal circuitry underlying compulsive behavior

Studies characterize activity of Alzheimer's disease candidate RO-4602522

Effects of AZD-5213 on sleep evaluated in patients with MCI and Alzheimer's disease

GlaxoSmithKline profiles pipeline progress of second quarter 2013

Memory improvements seen with insulin detemir in Alzheimer's disease, mild cognitive impairment

Hemophilia candidate concizumab evaluated in phase I trial

Sanofi researchers report antibodies targeting IL-13

New GPR119 receptor agonists patented by Hyundai Pharmaceutical

The Terasaki Family Foundation prepares novel IVIg mimetics

FDA grants market authorization for Cepheid's tuberculosis test

Vertex provides update on ongoing VX-135 trials in hepatitis C

Yakult Honsha begins phase I/II study of resminostat in NSCLC

EMA committee recommends Defitelio approval under exceptional circumstances

EMA's CHMP recommends approval of VEGF Trap-Eye/Eylea for new indication

PolyTherics merges with Antitope

Phosphagenics reaches milestone in development program for TPM/oxycodone patch

Genesis Biopharma and Lion Biotechnologies complete merger

EMA committee recommends approval of Revolade expanded indication

EMA issues negative opinion on delamanid for tuberculosis

Captisol-enabled topiramate injection receives FDA orphan drug status

Adimab licenses antibody discovery platform to Biogen Idec and GSK

Novartis' dual bronchodilator QVA-149 recommended for approval in COPD by CHMP

Gilead receives positive opinion from EMA for cobicistat

EMA committee recommends approval of three Takeda type 2 diabetes therapies

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 10, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...